Skip to main content

What the FDA labels say about taking them together

Fluvoxamine and midazolam

Fluvoxamine's FDA label of June 27, 2026 names midazolam in its warnings and precautions section; the midazolam labels PlainMeds reads (4) do not name fluvoxamine. The fluvoxamine label: “Other Potentially Important Drug Interactions Benzodiazepines: Benzodiazepines metabolized by hepatic oxidation should be used with caution because the clearance of these drugs is likely to be reduced by fluvoxamine.”

Check it at the source: the fluvoxamine FDA label on DailyMed (effective June 27, 2026, Zydus Pharmaceuticals USA Inc.); the midazolam FDA label on DailyMed (effective January 1, 2024, Fresenius Kabi USA, LLC).

What does the fluvoxamine label say about midazolam?

Fluvoxamine label, warnings and precautions

Other Potentially Important Drug Interactions Benzodiazepines: Benzodiazepines metabolized by hepatic oxidation (e.g., alprazolam, midazolam, triazolam, etc.) should be used with caution because the clearance of these drugs is likely to be reduced by fluvoxamine.

Source: FDA drug label (Fluvoxamine maleate extended-release), Zydus Pharmaceuticals USA Inc., effective June 27, 2026 (SPL set 6c71d4f6-54b5-4d3a-8d2f-b7773c92c32e), via openFDA; the full label on DailyMed

What does the midazolam label say about fluvoxamine?

Midazolam's label (effective January 1, 2024) and its 3 other brand-application labels do not name fluvoxamine in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (Midazolam), Fresenius Kabi USA, LLC, effective January 1, 2024 (SPL set 1cc9ba6e-fa1b-405e-9de8-720c567b2a73), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

16Fluvoxamine generic labelers
22Midazolam generic labelers
FluvoxamineMidazolam
Labeled forn/an/a
Boxed warningYesYes
Pharmacy cost (NADAC)$4.08 per capsule 100 mg capsule$0.233 per mL 2 mg/2 mL vial
Shortage nowNo current entryIn shortage

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?